Atlas Trials

Induction Chemo-Immunotherapy + Radiotherapy vs Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma

Clinical trial NCT07559045 · RECRUITING

Trial details

NCT number
NCT07559045
Sponsor
Second Affiliated Hospital of Zunyi Medical University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Squamous Cell Carcinoma (ESCC)
Start date
2026-01-01
Primary completion
2028-01-01
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.